MCRB

Seres Therapeutics, Inc. (MCRB)

NASDAQ: MCRBUSD
9.27 USD
+0.49 (+5.58%)
AT CLOSE (11:59 AM EDT)
9.25
-0.02 (-0.23%)
POST MARKET (AS OF 07:44 PM EDT)
🔴Market: CLOSED
Open?$8.76
High?$9.34
Low?$8.76
Prev. Close?$9.27
Volume?76.9K
Avg. Volume?50.3K
VWAP?$9.10
Rel. Volume?1.53x
Bid / Ask
Bid?$9.00 × 2.0K
Ask?$9.80 × 100
Spread?$0.80
Midpoint?$9.40
Valuation & Ratios
Market Cap?88.9M
Shares Out?9.6M
Float?6.6M
Float %?72.7%
P/E Ratio?15.60
P/B Ratio?2.01
EPS?$0.59
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.56Strong
Quick Ratio?2.56Strong
Cash Ratio?2.37Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score
67/100
P/E?
15.6CHEAP
P/B?
2.01CHEAP
P/S?
112.63HIGH
P/FCF?
102.7PRICEY
EV/EBITDA?
-0.5CHEAP
EV/Sales?
54.62HIGH
Returns & Efficiency
ROE?
12.9%STRONG
ROA?
4.1%FAIR
Cash Flow & Enterprise
FCF?$865.0K
Enterprise Value?$43.1M
Related Companies
Loading...
News
Profile
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
Employees
66
Market Cap
88.9M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2015-06-26
Address
200 SIDNEY STREET
CAMBRIDGE, MA 02139
Phone: 617 945 9626